跳至主要内容
临床试验/NCT02698878
NCT02698878已完成不适用

Effects of Nutrition and Neuromuscular Electrical Stimulation on Local Glucose Uptake Into m. Soleus During 60 Days of Lower Leg Unloading

DLR German Aerospace Center0 个研究点目标入组 13 人开始时间: 2014年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
13
主要终点
Changes in Local Glucose Uptake into m. soleus

研究概览

简要总结

The present study aimed to investigate whether a daily intake of lupin protein and a neuromuscular electrical stimulation training twice a day can improve local glucose uptake into m. soleus during a 60 day unloading phase with a special unloading device, the HEPHAISTOS orthosis (HEP).

详细描述

The 60 day unloading intervention with the HEPHAISTOS unloading device had the following key objectives:

primary hypothesis:

  • Assesment and evaluation of insulin sensitivity and local glucose uptake in the unloaded m. soleus and whether it can be improved by dietary supplementation of lupin seeds and neuromuscular electrical stimulation.

secondary hypotheses:

  • Assesment and evaluation of unloading-induced reductions in muscle mass and whether they can be mitigated by dietary supplementation of lupin seed and neuromuscular electrical stimulation.
  • Assesment and evaluation of whole-body glycemic effects of the interventions.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 45 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Male volunteers
  • Age: between 20 and 45 years
  • Body mass index (BMI): 20 -26 kg/m2
  • Agreement and signed consent before the study

排除标准

  • Competitive Athletes
  • Diabetes mellitus
  • Rheumatic disease
  • Muscle or joint disease
  • Bone fractures in the period up to one year before study start
  • Herniated disc
  • Flatfeet (pes planus)
  • Allergy to nuts or legume
  • Vascular diseases
  • Severe hyperlipidemia
  • Anemia (< Hb standard values; standard values healthy men: 13.5 -17.5 g/dl) *
  • Increased thrombosis risk *
  • Kidney disorder: deviations from normal values for creatinine in plasma. (Normal value: Creatinine < 1.20 mg/dl)*
  • Lesions of the cruciate ligaments, or orthopedic surgery in the past 10 years on the side of the Hephaistos orthosis
  • Achilles tendon injury, or rupture in the past 10 years on the side of the orthosis
  • hyper-/hypocalcaemia (abnormal levels of calcium in the blood, normal level: 2.15 - 2.64 mmol/l)
  • Intake of anti-inflammatory drugs during the study
  • Abuse of drugs or alcohol (> than 20-30g alcohol/day)
  • Participation in another clinical study within the last 2 months before the start of this study
  • Increased bleeding tendency (hemophilia, regular use of anticoagulants)
  • History of intolerance to local anesthetics
  • Imprisoned during study
  • Any other condition classed as unsuitable for study participation by the medical executive director
  • prior convictions (objectionable criminal record)
  • Additional Exclusion Criteria for MRI
  • Metal implants or other osteosynthesis material
  • Pacemaker
  • Claustrophobia

结局指标

主要结局

Changes in Local Glucose Uptake into m. soleus

时间窗: Baseline to day 59 of the intervention phase

Biopsies were taken from m. soleus

Changes in Local Glucose Metabolism in m. soleus

时间窗: Baseline to day 60 of the intervention phase

Microdialysis was performed in m. soleus

次要结局

  • Changes in Muscle Function (jump performance)(Baseline to day 58 of the intervention phase)
  • Blood Glucose (changes in the whole body glucose metabolism)(Baseline and day 2 & 1 before the intervention phase, day 4, 14, 28, 42 & 60 of the intervention phase and day 2 & 14 after the intervention phase)
  • Changes in Muscle Function (MVC)(Baseline to day 58 of the intervention phase)
  • Compliance(During 60 days of intervention)
  • Blood C-Peptide (changes in the whole body glucose metabolism)(Baseline and day 2 & 1 before the intervention phase, day 4, 14, 28, 42 & 60 of the intervention phase and day 2 & 14 after the intervention phase)
  • Blood HbA1c (changes in the whole body glucose metabolism)(Baseline and day 2 & 1 before the intervention phase, day 4, 14, 28, 42 & 60 of the intervention phase and day 2 & 14 after the intervention phase)
  • Blood Fructosamine (changes in the whole body glucose metabolism)(Baseline and day 2 & 1 before the intervention phase, day 4, 14, 28, 42 & 60 of the intervention phase and day 2 & 14 after the intervention phase)
  • Changes in Muscle Volume(Baseline to day 58 of the intervention phase)
  • Insulin Sensitivity (changes in the whole body glucose metabolism)(Baseline and day 60 of the intervention phase)
  • Movement(During 60 days of intervention and during 14 days of the recovery phase (post intervention phase))

研究者

申办方类型
Other
责任方
Sponsor

相似试验